NCT05479474NARecruiting

Platelet Rich Plasma Testis Treatment for Infertile Men

Stanford University

Start Date

1/18/2023

Completion Date

12/31/2026

Summary

Investigate the effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and IVF outcomes in infertile men who already underwent a negative sperm retrieval. Currently, there is no alternative treatment after failed TESE. Prior series suggest that intratesticular PRP injections may improve TESE outcomes. We hope to determine whether PRP is an effective treatment for this patient population.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Men over the age of 18 diagnosed with NOA and at least one failed TESE, negative mapping or negative biopsy Exclusion Criteria: \-

Interventions

BIOLOGICAL

Platelet rich plasma

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Male InfertilityNonobstructive AzoospermiaAzoospermia

Locations

Stanford Urology Clinic

Stanford, California 94304

United States